621
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan

, , , , &
Pages 444-453 | Accepted 22 Dec 2011, Published online: 07 Feb 2012

References

  • Nakai S, Suzuki K, Masakane I, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 2010;14:505‐40
  • The Japanese Society for Clinical Renal Transplantation. Annual Progress Report from the Japanese Renal Transplant Registry: number of renal transplantation in 2008, part 2. Jpn J Transplant 2009;44:548‐58 [Japanese]
  • Organisation for Economic Co-operation and Development Advisory. OECD statistical profile for Japan – 2006. OECD Statistics v.4.3, 2006. http://stats.oecd.org/wbos/viewhtml.aspx?query name=321&querytype=view&lang=en. Accessed March 30, 2011
  • Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009;13:621-30
  • Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:112-9
  • Vestergaard P, Løkkegaard H. Predicting future trends in the number of patients on renal replacement therapy in Denmark. Nephrol Dial Transplant 1997;12:2117-23
  • Schaubel DE, Morrison HI, Desmeules M, et al. End-stage renal disease in Canada: prevalence projections to 2005. CMAJ 1999;160:1557--63
  • Howard K, Salkeld G, White S, et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) 2009;14:123-32
  • Haller M, Gutjahr G, Kramar R, et al. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011;26:2988-95
  • Inaguma D, Tatematsu M, Shinjo H, et al. Effect of an educational program on the predialysis period for patients with chronic renal failure. Clin Exp Nephrol 2006;10:274-8
  • Beck JR, Pauker SG. Markov models in medical process in Medical prognosis. Med Decis Making 1983;3:419-58
  • Sonnenberg FA, Beak JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-38
  • The Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of December 31, 2008 (CD-R version), 2009 [Japanese]
  • Mitome J, Yamamoto H, Kato N, et al. Dialysis as bridge therapy for renal transplantation: single center experience, a comparison of hemodialysis and continuous ambulatory peritoneal dialysis. Jpn J Nephrol 2005;47:813-20 [Japanese]
  • Matsuo N, Maruyama Y, Terawaki H, et al. Risk factors for death in patients starting PD for their first renal replacement therapy. Jpn J Nephrol 2009;51:38-43 [Japanese]
  • The Japanese Society for Clinical Renal Transplantation, The Japanese Society for Transplantation. Annual progress report from the Japanese Renal Transplant Registry, 2007: part III: results from 2006 follow-up survey. Jpn J Transplant 2007;6:545-57 [Japanese]
  • Gorodetskaya I, Zenios S, McCulloch CE, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 2005;68:2801-8
  • Lee AJ, Morgan CL, Conway P, et al. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin 2005;21:1777-83
  • Groome PA, Hutchinson TA, Tousignant P, et al. The repeatability of three methods for measuring prospective patients' values in the context of treatment choice for end-stage renal disease. J Clin Epidemiol 1999;52:849-60
  • Higashiyama A, Okamura T, Watanabe M, et al. Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population. Hypertens Res 2009;32:450-4
  • Nakatani T, Uchida J, Naganuma T. Health economics of kidney transplant. Jpn J Transplant 2009;44:18-25 [Japanese]
  • Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004;44:729-37
  • Organisation for Economic Co-operation and Development Advisory. OECD Economic Outlook No. 89 Annex Tables 36 - Table of Contents, 2010. http://www.oecd.org/document/3/0,3746,en_2649_34573_2483901_1_1_1_1,00.html. Accessed September 3, 2011
  • Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. New York, NY: Oxford University Press, 2005. p 103-36
  • Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000;20:332-42
  • United States Renal Data System. Annual Data Report 2010 Atlas of CKD & ESRD. Transplantation 2010;2:311–24. http://www.usrds.org/atlas.htm. Accessed October 2, 2010
  • United Nations. Demographic Yearbook Regular Issues 2008. 2008, p 116–54. http://unstats.un.org/unsd/demographic/products/dyb/2000_round.htm. Accessed March 31, 2011
  • Winkelmayer WC, Weinstein MC, Mittleman MA, et al. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making 2002;22:417-30
  • The Japan Society for Transplantation. Fact book of organ transplant, 2010. http://www.asas.or.jp/jst/report_top.html. Accessed September 1, 2011 [Japanese]
  • Crowley-Matoka M, Lock M. Organ transplantation in a globalised world. Mortality 2006;11:166-81
  • Singh RP, Farney AC, Rogers J, et al. Kidney transplantation from donation after cardiac death donors. lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant 2010;25:255-64
  • Hoogland ER, Snoeijs MG, van Heurn LW. DCD kidney transplantation: results and measures to improve outcome. Curr Opin Organ Transplant 2010;15:177-82
  • Japan Organ Transplant Network. Data about the transplant analysis of brain-dead donor transplant, 2011. http://www.jotnw.or.jp/datafile/offer_brain.html. Accessed October 2, 2010 [Japanese]
  • Aita K. New organ transplant policies in Japan, including the family-oriented priority donation clause. Transplantation 2011;91:489-91
  • Milton CA, Russ GR, McDonald SP. Pre-emptive renal transplantation from living donors in Australia: effect on allograft and patient survival. Nephrology (Carlton) 2008;13:535-40
  • Hidai H. International comparison of dialysis cost -- particularly for health economics of low-income countries. J Jpn Assoc Dial Physicians 2005;20:145-52 [Japanese]
  • Takemoto Y, Naganuma T. International comparison of dialysis. J Jpn Assoc Dial Physicians 2007;22:64-8 [Japanese]
  • Sugisaki H, Ota Y, Kuma H, et al. The thirteenth report on the fact-finding survey of dialysis cost dialysis cost. J Jpn Assoc Dial Physicians 2010;25:56-86 [Japanese]
  • Hasegawa T, Bragg-Gresham JL, Pisoni RL, et al. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int 2011;79:340-6
  • Fukuhara S, Yamazaki C, Hayashino Y, et al. The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ 2007;7:217-31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.